Valuation Clinuvel Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. Other stock markets 02:10:10 2026-07-09 EDT			5-day change	1st Jan Change
10.45 ^AUD	+1.65%		+1.85%	-16.13%

07-01	Clinuvel Pharmaceuticals Extends CEO Philippe Wolgen's Term of Employment	MT
06-15	Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,517	733.7	883.5	769.8	520.3	518.4	-	-
Change	-	-51.63%	20.4%	-12.87%	-32.41%	-0.36%	-	-
Enterprise Value (EV) ¹	1,434	612.2	726.6	585.9	296.2	264.7	232.4	190.8
Change	-	-57.31%	18.69%	-19.37%	-49.45%	-10.63%	-12.22%	-17.9%
P/E	63.4x	36.8x	30.3x	22x	14.5x	14.4x	13.6x	10.4x
PBR	15.4x	5.84x	5.37x	3.79x	2.17x	1.88x	1.68x	1.46x
PEG	-	-2.2x	0.6x	1.2x	5.06x	-18.23x	2.1x	0.3x
Capitalization / Revenue	31.6x	11.2x	11.3x	8.73x	5.48x	5.21x	4.92x	3.92x
EV / Revenue	29.9x	9.32x	9.28x	6.64x	3.12x	2.66x	2.21x	1.44x
EV / EBITDA	55x	16.4x	19.5x	12x	6.84x	6.34x	5.23x	3.9x
EV / EBIT	56.8x	16.7x	20x	12.3x	7.03x	6.56x	5.35x	3.37x
EV / FCF	77.9x	15.5x	20.2x	18.6x	7.26x	8.36x	6.38x	3.41x
FCF Yield	1.28%	6.44%	4.94%	5.37%	13.8%	12%	15.7%	29.3%
Dividend per Share ²	0.025	0.04	0.05	0.05	0.05	0.0611	0.08	0.2257
Rate of return	0.08%	0.27%	0.28%	0.33%	0.48%	0.59%	0.78%	2.2%
EPS ²	0.484	0.403	0.591	0.698	0.718	0.7123	0.7585	0.9888
Distribution rate	5.17%	9.93%	8.46%	7.16%	6.96%	8.58%	10.5%	22.8%
Net sales ¹	47.98	65.72	78.32	88.18	95.02	99.46	105.4	132.1
EBITDA ¹	26.1	37.44	37.2	48.95	43.3	41.75	44.46	48.93
EBIT ¹	25.24	36.68	36.41	47.81	42.12	40.34	43.44	56.59
Net income ¹	24.73	20.88	30.6	35.64	36.17	35.97	38.2	49.83
Net Debt ¹	-82.69	-121.5	-156.8	-183.9	-224.1	-253.7	-286	-327.6
Reference price ²	30.70	14.85	17.88	15.37	10.38	10.28	10.28	10.28
Nbr of stocks (in thousands)	49,410	49,410	49,410	50,083	50,124	50,428	-	-
Announcement Date	8/26/21	8/30/22	8/29/23	8/28/24	8/27/25	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CLINUVEL PHARMACEUTICALS LIMITED	14.43x	2.66x	6.34x	0.59%	358M
REGENERON PHARMACEUTICALS, INC.	17.16x	3.76x	10.09x	0.59%	67.44B
UCB	26.81x	5.52x	16.19x	0.59%	53.98B
SAMSUNG BIOLOGICS CO.,LTD.	33.81x	11.45x	21.68x	-.--%	41.77B
CSL LIMITED	-46.24x	3.25x	9.6x	3.32%	41.15B
MODERNA, INC.	-8.52x	12.36x	-7.59x	-.--%	29.28B
BIOGEN INC.	30.53x	3.49x	11.03x	-.--%	29.58B
INCYTE CORPORATION	17.02x	3.26x	9.87x	-.--%	23.43B
INNOVENT BIOLOGICS, INC.	55.71x	6.01x	41.72x	-.--%	19.11B
SWEDISH ORPHAN BIOVITRUM AB	26.44x	5.42x	14.56x	-.--%	16.82B
Average	16.72x	5.72x	13.35x	0.51%	32.29B
Weighted average by Cap.	14.50x	5.92x	13.11x	0.64%